Valuation: Clover Corporation Limited

Market Cap 124M 85.81M 75.01M 68.94M 64.26M 122M 8.17B 828M 322M 4.02B 322M 315M 13.84B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 124M 85.81M 75.01M 68.94M 64.26M 122M 8.17B 828M 322M 4.02B 322M 315M 13.84B EV / Sales 2026 *
1.38x
EV / Sales 2027 * 1.3x
Free-Float
81.18%
Yield 2026 *
2.42%
Yield 2027 * 3.22%
1 day-9.15%
1 week-13.37%
Current month-11.83%
1 month-21.16%
3 months-28.71%
6 months-6.88%
Current year-5.70%
1 week 0.74
Extreme 0.745
0.86
1 month 0.74
Extreme 0.745
0.97
Current year 0.7
Extreme 0.7
1.16
1 year 0.52
Extreme 0.515
1.16
3 years 0.34
Extreme 0.337
1.22
5 years 0.34
Extreme 0.337
1.88
10 years 0.34
Extreme 0.337
3.31
Manager TitleAgeSince
Chief Executive Officer - 10/11/2014
Director of Finance/CFO - 05/05/2021
Chief Operating Officer - 02/02/2011
Director TitleAgeSince
Director/Board Member - 10/11/2014
Chairman - 20/09/2017
Director/Board Member - 31/01/2017
Date Insider Type Main position Quantity % Market Cap.
11-17Buy

Chief Executive Officer

529,638 0.3171%
11-17Sell

Chief Executive Officer

255,199 0.1528%
11-05Buy

Chief Financial Officer

2,447 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
-9.15%-13.37%+40.57%-39.18% 85.81M
-0.73%+1.42%+35.75%+93.05% 13.57B
+6.44%+44.53%-29.51%+236.53% 7.53B
+0.32%+1.19%-17.98%-61.44% 2.31B
+3.82%+20.00%-75.93%-62.35% 1.61B
+5.51%-15.00% - - 1.52B
+0.92%+4.55%+31.36%-6.09% 1.36B
-0.07%+7.52%-31.38%-25.17% 1.27B
+1.70%+5.13%-57.17%-62.56% 1.24B
+0.38%+2.29%+18.83%+39.82% 1.23B
Average +0.91%+6.50%-9.50%+12.51% 3.17B
Weighted average by Cap. +1.79%+10.44%+1.89%+90.36%

Financials

2026 *2027 *
Net sales 89.4M 62M 54.2M 49.81M 46.43M 88.06M 5.9B 598M 232M 2.9B 233M 228M 10B 95.3M 66.09M 57.78M 53.1M 49.49M 93.88M 6.29B 637M 248M 3.09B 248M 243M 10.66B
Net income - -
Net Debt - -
Logo Clover Corporation Limited
Clover Corporation Limited focused on technology, new product development, and commercialization. The principal activities of the Company are the refining and sale of natural oils, the production of encapsulated powders and the research and product development of functional food and infant nutrition ingredients. Its microencapsulation technology enables nutritional oils, such as tuna, fish, algal and fungal oils, to be added to infant formulas, foods, and beverages. Its technologies protect those sensitive oils from oxidation, allowing them to be incorporated into a range of applications. The Company, through its subsidiary, Nu-Mega Ingredients Pty Limited (Nu-Mega), supplies refined Omega-3 oils and a range of other encapsulated ingredients for use in infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. Nu-Mega’s Driphorm range of microencapsulated powders enables the addition of Hi-DHA tuna and/or algal oils to a broad spectrum of products.
Employees
68
Date Price Change Volume
03/07/26 A$0.7450 -9.15% 439,842
02/07/26 A$0.8200 0.00% 25,022
01/07/26 A$0.8200 -2.96% 28,049
30/06/26 A$0.8450 -0.59% 68,497
29/06/26 A$0.8500 -1.16% 78,736
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.7450AUD
Average target price
0.8700AUD
Spread / Average Target
+16.78%

Annual profits - Rate of surprise